Core Viewpoint - Tenon Medical, Inc. has successfully closed a private placement of senior convertible promissory notes, raising gross proceeds of $4.3 million to support its business operations and growth initiatives [1] Financial Details - The offering consists of notes with a principal amount of $4.3 million, featuring a 20% original issue discount and a maturity date set for September 11, 2026 [1] - The notes are convertible into shares of the company's common stock at a conversion price equal to 80% of the volume-weighted average price (VWAP) for the three trading days prior to conversion [1] Use of Proceeds - The net proceeds from the offering are intended for commercial expansion, product development, clinical studies, working capital, and general corporate purposes [1] Company Overview - Tenon Medical, Inc. is a medical device company established in 2012, known for its Catamaran SI Joint Fusion System, which offers a less invasive approach to treating sacro-pelvic disorders [1] - The Catamaran system utilizes a single titanium implant designed to stabilize the sacroiliac joint while avoiding critical neural and vascular structures [1] - Since its national launch in October 2022, the company is focusing on three commercial opportunities: primary SI joint procedures, revision procedures of failed implants, and augmenting spinal fusion [1]